BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 14608015)

  • 1. Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block.
    Desaphy JF; De Luca A; Didonna MP; George AL; Camerino Conte D
    J Physiol; 2004 Jan; 554(Pt 2):321-34. PubMed ID: 14608015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranolazine block of human Na v 1.4 sodium channels and paramyotonia congenita mutants.
    El-Bizri N; Kahlig KM; Shyrock JC; George AL; Belardinelli L; Rajamani S
    Channels (Austin); 2011; 5(2):161-72. PubMed ID: 21317558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide.
    Desaphy JF; Dipalma A; Costanza T; Bruno C; Lentini G; Franchini C; George A; Conte Camerino D
    Br J Pharmacol; 2010 Jul; 160(6):1521-33. PubMed ID: 20590641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative.
    Desaphy JF; De Luca A; Tortorella P; De Vito D; George AL; Conte Camerino D
    Neurology; 2001 Nov; 57(10):1849-57. PubMed ID: 11723275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
    Aoike F; Takahashi MP; Sakoda S
    Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels.
    Wang GK; Russell C; Wang SY
    J Physiol; 2004 Feb; 554(Pt 3):621-33. PubMed ID: 14608007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-dependent block of wild-type and inactivation-deficient Na+ channels by flecainide.
    Wang GK; Russell C; Wang SY
    J Gen Physiol; 2003 Sep; 122(3):365-74. PubMed ID: 12913091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate.
    Farinato A; Altamura C; Imbrici P; Maggi L; Bernasconi P; Mantegazza R; Pasquali L; Siciliano G; Lo Monaco M; Vial C; Sternberg D; Carratù MR; Conte D; Desaphy JF
    Pharmacol Res; 2019 Mar; 141():224-235. PubMed ID: 30611854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State-dependent trapping of flecainide in the cardiac sodium channel.
    Ramos E; O'leary ME
    J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of temperature and mexiletine on the F1473S Na+ channel mutation causing paramyotonia congenita.
    Fleischhauer R; Mitrovic N; Deymeer F; Lehmann-Horn F; Lerche H
    Pflugers Arch; 1998 Oct; 436(5):757-65. PubMed ID: 9716710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na(+) channel.
    Takahashi MP; Cannon SC
    J Physiol; 2001 Dec; 537(Pt 3):701-14. PubMed ID: 11744749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible block of cardiac mutant Na+ channels by batrachotoxin.
    Wang SY; Tikhonov DB; Mitchell J; Zhorov BS; Wang GK
    Channels (Austin); 2007; 1(3):179-88. PubMed ID: 18690024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na+ channels expressed in a mammalian cell line.
    Fan Z; George AL; Kyle JW; Makielski JC
    J Physiol; 1996 Oct; 496 ( Pt 1)(Pt 1):275-86. PubMed ID: 8910215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-aggravated myotonia mutations at residue G1306 differentially alter deactivation gating of human skeletal muscle sodium channels.
    Groome JR; Fujimoto E; Ruben PC
    Cell Mol Neurobiol; 2005 Nov; 25(7):1075-92. PubMed ID: 16392038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing use-dependent inhibition of the cardiac Na(+/-) current (I(Na)) in the PatchXpress automated patch clamp.
    Penniman JR; Kim DC; Salata JJ; Imredy JP
    J Pharmacol Toxicol Methods; 2010; 62(2):107-18. PubMed ID: 20601018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects on gating of three myotonia-causing mutations in the inactivation gate of the human muscle sodium channel.
    Mitrović N; George AL; Lerche H; Wagner S; Fahlke C; Lehmann-Horn F
    J Physiol; 1995 Aug; 487(1):107-14. PubMed ID: 7473241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians.
    Zhao J; Duprè N; Puymirat J; Chahine M
    J Physiol; 2012 Jun; 590(11):2629-44. PubMed ID: 22250216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
    Sheets MF; Hanck DA
    J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.
    Wang GK; Calderon J; Wang SY
    Mol Pharmacol; 2008 Mar; 73(3):940-8. PubMed ID: 18079277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation.
    Desaphy JF; Carbonara R; D'Amico A; Modoni A; Roussel J; Imbrici P; Pagliarani S; Lucchiari S; Lo Monaco M; Conte Camerino D
    Neurology; 2016 May; 86(22):2100-8. PubMed ID: 27164696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.